We focused on the effect of MMP-3 on the activation status of B cells based on the rationale that B cells found within the CNS/CSF compartment in progressive MS patients are found to be of an activated phenotype (8, 15, 49, 63). This evidence concerns the gene MMP3 and myeloid sarcoma.